Establishment and characterization of two distinct malignant mesothelioma cell lines with common clonal origin

Cancer Genetics and Cytogenetics

Volumn 176, Issue 1, 2007, Pages 35-47

  Schulten, Hans Jürgen ^a   Perske, Christina ^a   Thelen, Paul ^a   Polten, Andreas ^b   Borst, Christoph ^c   Gunawan, Bastian ^a   Nagel, Holger ^a,d  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b AGILENT TECHNOLOGIES   (Germany)

^c Friedrich Ebert Krankenhaus   (Germany)

^d LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETININ; CYTOKERATIN; VIMENTIN;

AGED; ANIMAL CELL; ARTICLE; CASE REPORT; CHROMOSOME 17; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC TRAIT; GENETICS; HUMAN; HUMAN CELL; MALE; MALIGNANT MESOTHELIOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CLONE CELLS; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MESOTHELIOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLEURAL EFFUSION, MALIGNANT; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 34250218931     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.03.005     Document Type: Article

References (25)

1. In: Travis W.D., Brambilla E., Müller-Hermelink H.K., and Harris C.C. (Eds). Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (2004), IARC Press, . Lyon
2. Simon F., Johnen G., Krismann M., and Muller K.M. Chromosomal alterations in early stages of malignant mesotheliomas. Virchows Arch 447 (2005) 762-767
3. Ceresoli G.L., Zucali P.A., Favaretto A.G., Grossi F., Bidoli P., Del Conte G., Ceribelli A., Bearz A., Morenghi E., Cavina R., Marangolo M., Parra H.J., and Santoro A. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. J Clin Oncol 24 (2006) 1443-1448
4. Gordon G.J., Rockwell G.N., Godfrey P.A., Jensen R.V., Glickman J.N., Yeap B.Y., Richards W.G., Sugarbaker D.J., and Bueno R. Validation of genomics-based prognostic tests in malignant pleural mesothelioma. Clin Cancer Res 11 (2005) 4406-4414
5. Kindler H.L., and Vogelzang N. Mesothelioma. In: Vokes E.E., and Golomb H. (Eds). Oncologic therapies (2003), Springer-Verlag, Berlin 415-423
6. Johansson L., and Linden C.J. Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas. Chest 109 (1996) 109-114
7. Shaffer L.G., and Tommerup N. ISCN 2005: An International System for Human Cytogenetic Nomenclature (2005), S. Karger, Basel
8. Gunawan B., Schulten H.J., von Heydebreck A., Schmidt B., Enders C., Hoer J., Langer C., Schuler P., Schindler C.G., Kuhlgatz J., and Füzesi L. Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours. J Pathol 202 (2004) 421-429
9. Kivipensas P., Bjorkqvist A.M., Karhu R., Pelin K., Linnainmaa K., Tammilehto L., Mattson K., Kallioniemi Q.P., and Knuutila S. Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization. Cancer Genet Cytogenet 89 (1996) 7-13
10. Ruco L.P., de Laat P.A., Matteucci C., Bernasconi S., Sciacca F.M., van der Kwast T.H., Hoogsteden H.C., Uccini S., Mantovani A., and Versnel M.A. Expression of ICAM-1 and VCAM-1 in human malignant mesothelioma. J Pathol 179 (1996) 266-271
11. Philippeaux M.M., Pache J.C., Dahoun S., Barnet M., Robert J.H., Mauel J., and Spiliopoulos A. Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis. Histochem Cell Biol 122 (2004) 249-260
12. Kumar K., Rahman Q., Schipper H., Matschegewski C., Schiffmann D., and Papp T. Mutational analysis of 9 different tumour-associated genes in human malignant mesothelioma cell lines. Oncol Rep 14 (2005) 743-750
13. Reale F.R., Griffin T.W., Compton J.M., Graham S., Townes P.L., and Bogden A. Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model. Cancer Res 47 (1987) 3199-3205
14. Sun X., Dobra K., Bjornstedt M., and Hjerpe A. Upregulation of 9 genes, including that for thioredoxin, during epithelial differentiation of mesothelioma cells. Differentiation 66 (2000) 181-188
15. Usami N., Fukui T., Kondo M., Taniguchi T., Yokoyama T., Mori S., Yokoi K., Horio Y., Shimokata K., Sekido Y., and Hida T. Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci 97 (2006) 387-394
16. Klominek J., Robert K.H., Hjerpe A., Wickstrom B., and Gahrton G. Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res 49 (1989) 6118-6122
17. Bjorkqvist A.M., Tammilehto L., Anttila S., Mattson K., and Knuutila S. Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br J Cancer 75 (1997) 523-527
18. Krismann M., Muller K.M., Jaworska M., and Johnen G. Molecular cytogenetic differences between histological subtypes of malignant mesotheliomas: DNA cytometry and comparative genomic hybridization of 90 cases. J Pathol 197 (2002) 363-371
19. Cheng J.Q., Jhanwar S.C., Lu Y.Y., and Testa J.R. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas. Cancer Res 53 (1993) 4761-4763
20. Nagel H., Schulten H.J., Gunawan B., Brinck U., and Füzesi L. The potential value of comparative genomic hybridization analysis in effusion-and fine needle aspiration cytology. Mod Pathol 15 (2002) 818-825
21. Illei P.B., Rusch V.W., Zakowski M.F., and Ladanyi M. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin Cancer Res 9 (2003) 2108-2113
22. Pelin-Enlund K., Husgafvel-Pursiainen K., Tammilehto L., Klockars M., Jantunen K., Gerwin B.I., Harris C.C., Tuomi T., Vanhala E., Mattson K., and Linnainmaa K. Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients. Carcinogenesis 11 (1990) 673-681
23. Knuuttila A., Jee K.J., Taskinen E., Wolff H., Knuutila S., and Anttila S. Spindle cell tumours of the pleura: a clinical, histological and comparative genomic hybridization analysis of 14 cases. Virchows Arch 448 (2006) 135-141
24. Metcalf R.A., Welsh J.A., Bennett W.P., Seddon M.B., Lehman T.A., Pelin K., Linnainmaa K., Tammilehto L., Mattson K., Gerwin B.I., and Harris C.C. p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res 52 (1992) 2610-2615
25. Cheng J.Q., Lee W.C., Klein M.A., Cheng G.Z., Jhanwar S.C., and Testa J.R. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation. Genes Chromosomes Cancer 24 (1999) 238-242